Effect of Propolis on moderate persistent asthma: A phase two randomized, double blind, controlled clinical trial

Publish Year: 1400
نوع سند: مقاله ژورنالی
زبان: English
View: 372

This Paper With 10 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_AJP-11-1_003

تاریخ نمایه سازی: 22 دی 1399

Abstract:

Objective: The aims of this study was to determine the effect of Propolis (resinous mixture that honey bees produce by mixing saliva and beeswax) on clinical and physiological findings of moderate persistent asthma. Materials and Methods: Fifty-two subjects aged 44.6±18.5 years old with moderate asthma and Forced expiratory volume in 1 second (FEV1) 60-79% of predicted, were enrolled in this clinical trial. We randomly allocated subjects to receive either propolis (75 mg three times a day) or a matched placebo for one month. Primary outcome was Asthma control test (ACT) score and secondary outcomes included dyspnea, spirometry, fractional exhaled nitric oxide (FENO) and sputum cytology including inflammatory cell. Sputum induction was done by hypertonic saline and cytology slides were stained by Papanicolaou stain. Results: Clinical findings significantly improved after the treatment. ACT scores significantly increased by using propolis (12.8±5.5 before and 18.1±4.99 after the trial), which was significantly higher than the placebo group (14.4±6.6 after the trial). The most significant physiological improvements were significant increases in FEV1, FV1/Forced vital capacity and expiratory flows. FENO showed significant decreases in the propolis group but increases in the placebo group. Cytological examination of sputum showed that the pattern of inflammation was eosinophilic in 44% subjects with an average eosinophil of 7.2±1.01%. Eosinophilia significantly decreased (p <0.05) by using propolis (7.2±1.01 and 4.3±3.1%, before and after treatment, respectively), but it significantly increased (p <0.04) in the placebo group (5.5±2.8, and 11.1±6.6%, before and after treatment, respectively). Conclusion: Propolis improved the clinical and physiological findings of moderate persistent asthma, and it was able to suppress eosinophilic inflammation.

Keywords:

Propolis , Asthma , caffeic acid phenethyl ester , Quercetin , naringenin

Authors

Majid Mirsadraee

Department of Internal Medicine, Faculty of Medicine, Islamic Azad University, Mashhad Branch, Mashhad, Iran

Bahareh Azmoon

Innovative Medical Research Center, Faculty of Medicine, Islamic Azad University, Mashhad Branch, Mashhad, Iran

Shadi Ghaffari

Shahid Hasehemi Nezhad Research Center, Kavosh High School, Ministry of Education, Mashhad, Iran

Aboutaleb Abdolsamadi

Independent Pharmacist

Mohammad reza Khazdair

Cardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran